Location History:
- Bahama, NC (US) (2002 - 2016)
- Durham, NC (US) (2021 - 2022)
Company Filing History:
Years Active: 2002-2022
Title: Salvatore Pizzo: Innovator in Antibody Research
Introduction
Salvatore Pizzo is a notable inventor based in Bahama, NC (US), recognized for his contributions to the field of antibody research. He holds a total of 9 patents, showcasing his innovative approach to addressing complex medical conditions.
Latest Patents
Pizzo's latest patents include groundbreaking work on anti-pro-N-cadherin antibodies and methods for treating pathological fibrotic conditions and tumor cells. His humanized antibody targets a mislocated form of N-cadherin, effectively detecting and eliminating cells that express the protein extracellularly. These cells are often found in fibrotic conditions affecting the heart, lung, liver, kidney, skin, and other organs. Importantly, this antibody does not impact cells with a normal, subcellular location of the protein. Additionally, he has developed compositions and methods for detecting and treating pathological fibroblast cells, providing valuable tools for assessing the presence of these cells within biological samples and offering methods for treating fibrosis.
Career Highlights
Throughout his career, Salvatore Pizzo has made significant strides in the medical research community. His work has been instrumental in advancing the understanding and treatment of fibrotic conditions, which are critical areas of study in modern medicine.
Collaborations
Pizzo has collaborated with esteemed institutions such as Duke University and Northwestern University. He has also worked alongside notable colleagues, including Tammy L. Moser and Mary S. Stack, contributing to a collaborative environment that fosters innovation.
Conclusion
Salvatore Pizzo's contributions to antibody research and treatment methodologies highlight his role as a leading inventor in the field. His innovative patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.